Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Batch-verified · ≥99.0% purity (HPLC) Batch ZL-28-10 · Tested by Janoshik Analytical · 17/06/2026
View COA
Growth Hormone Research

Sermorelin 10mg

GHRH (1-29) analogue

Be the first to review SKU: APC-SERMORELIN-10MG
Purity
≥99.0%
Lab Tested
Third-Party
Batch Specific
COA
$84.99 AUD
In Stock
Quantity
Order within for same-day dispatch
Secure CheckoutSSL Encrypted
Fast Australia WideDiscreet Shipping
Orders before 2pm AESTDispatched Same Day

Also searched as: GRF 1-29, Sermorelin acetate

Trusted Zynova Labs Supplier Genuine Zynova Labs research vials, stocked and dispatched from Melbourne.

Third-Party Tested

HPLC & mass spec verified purity

Batch Specific COA

Certificate with every batch

Discreet Packaging

Plain, unbranded, tamper-evident

Same-Day Dispatch

Before 2PM AEST, Australia-wide

Sermorelin is a synthetic peptide analogue based on the growth hormone-releasing hormone (GHRH) sequence and is studied primarily in endocrine and growth hormone signalling research. Supplied as a lyophilised research material, Sermorelin peptide is of scientific interest because of its interaction with GHRH receptors and its role in experimental investigations of growth hormone regulation. It is intended exclusively for controlled laboratory and scientific research and should be handled according to appropriate laboratory procedures.

What Is Sermorelin?

Sermorelin is a 29-amino-acid peptide corresponding to the biologically active N-terminal portion of human GHRH. This region retains the ability to interact with the growth hormone-releasing hormone receptor (GHRHR), making Sermorelin useful for studying signalling associated with growth hormone secretion.

Activation of GHRHR is associated with intracellular signalling involving cyclic adenosine monophosphate (cAMP) and downstream pathways involved in growth hormone release. Researchers have therefore examined Sermorelin when investigating endocrine signalling, pituitary function and the broader growth hormone/IGF-1 axis.

Unlike growth hormone itself, Sermorelin is studied as an upstream GHRH receptor agonist rather than as a direct replacement for growth hormone.

ManufacturerZynova Labs
Strength10mg
Molecular FormulaC149H246N44O42S
Molecular Weight3357.9 g/mol
Purity≥99.0% (HPLC, batch ZL-28-10)
AppearanceWhite lyophilised powder
CAS No.86168-78-7
FormLyophilised Powder
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryGrowth Hormone Research
UsageFor Research Use Only. Not for human consumption.

Key Research Areas

Sermorelin research has primarily focused on endocrine and peptide signalling. Relevant areas include:

These areas represent research interests rather than evidence that Sermorelin produces specific therapeutic outcomes.

Why Researchers Study Sermorelin

One reason Sermorelin attracts scientific interest is its relatively well-defined relationship with the endogenous GHRH pathway. Its 29-amino-acid sequence represents the portion of GHRH required for biological activity, providing researchers with a targeted compound for investigating receptor-mediated endocrine signalling.

Sermorelin may also be useful in comparative experiments involving other growth hormone secretagogues. GHRH-related peptides act through GHRH receptors, whereas compounds such as ghrelin mimetics interact primarily with the growth hormone secretagogue receptor, GHS-R1a.

These distinct receptor pathways allow researchers to examine different mechanisms involved in growth hormone regulation without assuming that experimental findings translate directly into human outcomes.

Key Research Areas at a Glance

GHRH receptor activity investigating interactions between peptide ligands and GHRHR.
Growth hormone signalling examining mechanisms regulating growth hormone secretion.
GH/IGF-1 axis exploring downstream endocrine signalling associated with growth hormone activity.
Pituitary research studying the physiological regulation of somatotroph cells and hormone release.
Age-related endocrine research investigating how growth hormone signalling and responsiveness may change across biological ageing models.

Sermorelin in Australia

Researchers looking for Sermorelin Australia products should consider analytical documentation, batch traceability, stated purity and appropriate laboratory packaging rather than relying solely on headline concentration claims.

Before ordering Sermorelin online Australia, laboratories should confirm the current stock status, vial specification, testing method, Certificate of Analysis availability, price and domestic shipping information directly from the supplier.

Sermorelin should be purchased and handled solely for legitimate laboratory and scientific research purposes.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameSermorelin 10mg
ManufacturerZynova Labs
Strength10mg
Molecular FormulaC149H246N44O42S
Molecular Weight3357.9 g/mol
Purity≥99.0% (HPLC, batch ZL-28-10)
AppearanceWhite lyophilised powder
CAS No.86168-78-7
FormLyophilised Powder
VialSealed, sterile glass vial
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryGrowth Hormone Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality, Purity and Batch Testing

Sermorelin supplied for laboratory research should be accompanied by clear analytical documentation wherever available. Relevant quality information may include the nominal quantity per vial, stated purity, batch identification and analytical testing.

High-performance liquid chromatography (HPLC) can be used to assess peptide purity, while mass spectrometry or LC-MS may assist with confirming molecular identity.

Where a batch-specific Sermorelin CoA is provided, researchers should consult that document for the analytical results applying to the specific batch. Analytical purity or identity testing should not be interpreted as evidence of clinical safety or therapeutic effectiveness.

CERTIFICATE OF ANALYSIS
Sermorelin 10mg
Batch: ZL-28-10 · 17/06/2026
Janoshik Analytical Certificate of Analysis for Sermorelin 10mg

Storage & Handling

Storage and Laboratory Handling

  • Lyophilised Storage: Researchers should follow the storage conditions stated on the product label, batch documentation or Certificate of Analysis.
  • After Reconstitution: Where validated post-reconstitution stability information is not supplied, researchers should follow their established laboratory protocol and applicable batch documentation.

Avoid assuming a specific shelf life, solvent, concentration or stability period unless these have been verified for the relevant material.

Unopened VialStore at -20°C, protect from light & moisture
ReconstitutionBacteriostatic water (recommended)
After ReconstitutionRefrigerate at 2–8°C, use within 4 weeks
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: Sermorelin 10mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

Sermorelin 10mg: Frequently Asked Questions

Sermorelin is a synthetic 29-amino-acid peptide derived from the biologically active region of human growth hormone-releasing hormone.

It acts as a GHRH receptor agonist, allowing researchers to investigate receptor signalling associated with growth hormone regulation.

Its sequence represents the N-terminal region of GHRH responsible for much of the peptide's biological receptor activity.

Research has examined GHRH receptor activity, pituitary signalling, growth hormone regulation and the GH/IGF-1 axis.

This depends on the individual batch. Researchers should review the applicable product specification and analytical documentation.

Where batch-specific CoA documentation is supplied, it may provide information concerning purity, identity and analytical testing.

Follow the verified storage conditions provided with the specific product and its batch documentation.

Researchers should use an Australian research supplier that provides clear specifications, analytical documentation and current shipping and stock information.

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “Sermorelin 10mg”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products